Residual keratan sulfate in chondroitin sulfate formulations for oral administration

Carbohydrate Polymers

Volumn 90, Issue 2, 2012, Pages 839-846

  Pomin, Vitor H ^a   Piquet, Adriana A ^a   Pereira, Mariana S ^a   Mourão, Paulo A S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Chondroitin sulfate; Glycosaminoglycan; Keratan sulfate; Osteoarthrosis; Quality control

Indexed keywords

CELLULOSE ACETATES; CHONDROITIN SULFATES; DIETARY SUPPLEMENTS; GLYCOSAMINOGLYCANS; HAZARDOUS EFFECTS; INERT MATERIALS; KERATAN SULFATE; ORAL ADMINISTRATION; OSTEOARTHROSIS; STRONG ANION-EXCHANGE CHROMATOGRAPHY; URONIC ACIDS;

CARBOXYLIC ACIDS; ELECTROPHORESIS; HYDROGELS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; QUALITY CONTROL; SIZE EXCLUSION CHROMATOGRAPHY;

SULFUR COMPOUNDS;

CHONDROITIN SULFATE; KERATAN SULFATE; SHARK CARTILAGE EXTRACT; TISSUE EXTRACT;

ANIMAL; ARTICLE; CARTILAGE; CATTLE; CHEMISTRY; DRUG CONTAMINATION; EVALUATION; HUMAN; NUCLEAR MAGNETIC RESONANCE; ORAL DRUG ADMINISTRATION; SHARK;

ADMINISTRATION, ORAL; ANIMALS; CARTILAGE; CATTLE; CHEMISTRY, PHARMACEUTICAL; CHONDROITIN SULFATES; DRUG CONTAMINATION; HUMANS; KERATAN SULFATE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SHARKS; TISSUE EXTRACTS;

CHONDRICHTHYES;

EID: 84864435639     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2012.06.009     Document Type: Article

References (20)

1. T. Bitter, and H.M. Muir A modified uronic acid carbazole reaction Analytical Biochemistry 4 1962 330 334
2. D.B. Blossom, A.J. Kallen, P.R. Patel, A. Elward, L. Robinson, and G. Gao Outbreak of adverse reactions associated with contaminated heparin The New England Journal of Medicine 359 2008 2674 2684
3. D.O. Clegg, D.J. Reda, C.L. Harris, M.A. Klein, J.R. O'Dell, and M.M. Hooper Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis The New England Journal of Medicine 354 2006 795 808 (Pubitemid 43290918)
4. 13C assignments of keratan sulphate from shark cartilage Biochemical Journal 236 1986 921 924 (Pubitemid 16067138)
5. European Pharmacopoeia European directorate for the quality of medicines 6th ed. 2007 Strasbourg France
6. R.J. Fonseca, S.N. Oliveira, V.H. Pomin, A.S. Mecawi, I.G. Araujo, and P.A. Mourão Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges for the study of anticoagulant polysaccharides Thrombosis and Haemostasis 103 2010 994 1004
7. B. Gesselbauer, and A.J. Kungl Glycomic approaches toward drug development: Therapeutically exploring the glycosaminoglycanome Current Opinion in Molecular Therapeutics 8 2006 521 528 (Pubitemid 44921808)
8. M. Guerrini, D. Beccati, Z. Shriver, A. Naggi, K. Viswanathan, and A. Bisio Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events Nature Biotechnology 26 2008 669 675 (Pubitemid 351824692)
9. G.C. Leta, P.A. Mourão, and A.M. Tovar Human venous and arterial glycosaminoglycans have similar affinity for plasma low-density lipoproteins Biochimica et Biophysica Acta 1586 2002 243 253 (Pubitemid 34460699)
10. J.F.K. Limtiaco, C.J. Jones, and C.K. Larive Diffusion-edited NMR spectra of heparin contaminants Analytical Methods 4 2012 1168 1172
11. V.H. Pomin, and P.A. Mourão Structure, biology, evolution, and medical importance of sulfated fucans and galactans Glycobiology 18 2008 1016 1027
12. V.H. Pomin, Y. Park, R. Huang, C. Heiss, J. Sharp, and P. Azadi Exploiting enzyme especificities in digestions of chondroitin sulfates A and C: Production of well-defined hexasaccharides Glycobiology 22 2012 826 838
13. V.H. Pomin, J.S. Sharp, X. Li, L. Wang, and J.H. Prestegard Characterization of glycosaminoglycan by 15N NMR spectroscopy and in vivo isotopic labeling Analytical Chemistry 82 2010 4078 4088
14. V.H. Pomin, A.-P. Valente, M.S. Pereira, and P.A. Mourão Mild acid hydrolysis of sulfated fucans: A selective 2-desulfation reaction and an alternative approach for preparing tailored sulfated oligosaccharides Glycobiology 15 2005 1376 1385 (Pubitemid 41724342)
15. 1H NMR spectra The Analyst 136 2011 1390 1398
16. C. Schiraldi, D. Cimini, and M. De Rosa Production of chondroitin sulfate and chondroitin Applied Microbiology and Biotechnology 87 2010 1209 1220
17. K. Sugahara, T. Mikami, T. Uyama, S. Mizugushi, K. Nomura, and H. Kitagawa Recent advances in structural biology of chondroitin sulfate and dermatan sulfate Current Opinion in Structural Biology 13 2003 612 620 (Pubitemid 37244117)
18. United States Pharmacopoeia United States pharmacopeial convention 32nd ed. 2008 US Pharmacopeia Rockville, MD, USA
19. N. Volpi Analytical aspects of pharmaceutical grade chondroitin sulfates Journal of Pharmaceutical Sciences 96 2007 3168 3180
20. T. Zhang, B. Li, J. Suwan, F. Zhang, Z. Wang, and H. Liu Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE Journal of Pharmaceutical Science 98 2009 4017 4026